Lactoferrin and Its Potential Impact for the Relief of Pain: A Preclinical Approach

Pharmaceuticals - Tập 14 Số 9 - Trang 868
Beatriz Godínez‐Chaparro1, Fabiola Guzmán-Mejía1, María Elisa Drago-Serrano1
1Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana Unidad Xochimilco, Calzada del Hueso No. 1100, Ciudad de México 04960, Mexico

Tóm tắt

Pain is one of the most disabling symptoms of several clinical conditions. Neurobiologically, it is classified as nociceptive, inflammatory, neuropathic and dysfunctional. Opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) are conventionally prescribed for the treatment of pain. Long-term administration of opioids results in the loss of analgesic efficacy, leading to increased dosage, tolerance, and addiction as the main drawbacks of their use, while the adverse effects of NSAIDs include gastric ulcer formation, intestinal bleeding, acute kidney injury, and hepatotoxicity. Lactoferrin is an iron-binding, anti-inflammatory glycoprotein that displays analgesic activities associated, in part, by interacting with the low-density lipoprotein receptor-related protein (LRP), which may result in the regulation of the DAMP–TRAF6–NFκB, NO–cGMP–ATP K+-sensitive channel and opioid receptor signaling pathways. This review summarizes and discusses for the first time the analgesic effects of lactoferrin and its presumable mechanisms based on pre-clinical trials. Given its anti-nociceptive and anti-inflammatory properties, lactoferrin may be used as an adjunct to enhance the efficacy and to decrease the tolerogenic effects of canonical therapeutic drugs prescribed for pain treatment.

Từ khóa


Tài liệu tham khảo

Cervero, 2009, Pain: Friend or foe? A neurobiologic perspective: The 2008 Bonica Award lecture, Reg. Anesth. Pain Med., 34, 569, 10.1097/AAP.0b013e3181b4c517

(2018, July 09). IASP Terminology: Washington, DC, USA: International Association for the Study of Pain. Available online: https://www.iasp-pain.org/terminology?%0A.

Freynhagen, 2019, Current understanding of the mixed pain concept: A brief narrative review, Curr. Med. Res. Opin., 35, 1011, 10.1080/03007995.2018.1552042

Colloca, 2017, Neuropathic Pain, Nat. Rev. Dis. Prim., 16, 749

Cavalli, E., Mammana, S., Nicoletti, F., Bramanti, P., and Mazzon, E. (2019). The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int. J. Immunopathol. Pharmacol., 33.

Fitzcharles, 2021, Nociplastic pain: Towards an understanding of prevalent pain conditions, Lancet, 397, 2098, 10.1016/S0140-6736(21)00392-5

Kosek, E., Clauw, D., Nijs, J., Baron, R., Gilron, I., Harris, R.E., Mico, J.-A., Rice, A.S.C., and Sterling, M. (2021). Chronic nociplastic pain affecting the musculoskeletal system. Pain.

Ahlbeck, 2011, Opioids: A two-faced Janus, Curr. Med. Res. Opin., 27, 439, 10.1185/03007995.2010.545379

Remesic, 2017, Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics Michael, ACS Chem. Neurosci., 8, 1147, 10.1021/acschemneuro.7b00090

Cervero, F. (2014). Undersanding Pain, The MIT Press.

Atkinson, 2020, Nonsteroidal Antiinflammatory Drugs for Acute and Chronic Pain, Phys. Med. Rehabil. Clin. N. Am., 31, 219, 10.1016/j.pmr.2020.01.002

Bindu, 2020, Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective, Biochem. Pharmacol., 180, 114, 10.1016/j.bcp.2020.114147

Finnerup, 2016, Neuropathic pain: An updated grading system for research and clinical practice, Pain, 157, 1599, 10.1097/j.pain.0000000000000492

Ghayur, M.N. (2021). Case Report Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin. Case Rep. Med., 2.

Goldstein, 2002, Adjuncts to opioid therapy, J. Am. Osteopath. Assoc., 102, 15

Hayashida, 2003, Novel function of bovine milk-derived lactoferrin on antinociception mediated by μ-opioid receptor in the rat spinal cord, Brain Res., 965, 239, 10.1016/S0006-8993(02)04207-5

Yamaguchi, 2009, Novel functions of bovine milk-derived α-lactalbumin: Anti-nociceptive and anti-inflammatory activity caused by inhibiting cyclooxygenase-2 and phospholipase A2, Biol. Pharm. Bull., 32, 366, 10.1248/bpb.32.366

Rosa, L., Cutone, A., Lepanto, M.S., Paesano, R., and Valenti, P. (2017). Lactoferrin: A natural glycoprotein involved in iron and inflammatory homeostasis. Int. J. Mol. Sci., 18.

Yamauchi, 2000, 13-Week oral repeated administration toxicity study of bovine lactoferrin in rats, Food Chem. Toxicol., 38, 503, 10.1016/S0278-6915(00)00036-3

Okada, 2002, Dose-response Trial of Lactoferrin in Patients with Chronic Hepatitis C, Jpn. J. Cancer Res., 93, 1063, 10.1111/j.1349-7006.2002.tb02484.x

Giunta, 2012, Influence of lactoferrin in preventing preterm delivery: A pilot study, Mol. Med. Rep., 5, 162

Paesano, 2006, Oral administration of lactoferrin increases hemoglobin and total serum iron in pregnant women, Biochem. Cell Biol., 84, 377, 10.1139/o06-040

Manzoni, 2009, Bovine Lactoferrin Supplementation for Prevention of Late-Onset Sepsis in Very Low-Birth-Weight Neonates A Randomized Trial, JAMA, 302, 1421, 10.1001/jama.2009.1403

King, 2007, A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants, J. Pediatric Gastroenterol. Nutr., 44, 245, 10.1097/01.mpg.0000243435.54958.68

Miranda, 2019, Vaginal lactoferrin in prevention of preterm birth in women with bacterial vaginosis, J. Matern.-Fetal Neonatal Med., 2019, 1

Nakano, 2019, Effect of tablets containing lactoferrin and lactoperoxidase on gingival health in adults: A randomized, double-blind, placebo-controlled clinical trial, J. Periodontal Res., 54, 702, 10.1111/jre.12679

Pammi, M., and Gautham, S. (2017). Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Data Base Syst. Rev., 6.

Du, 2021, Biological activities of commercial bovine lactoferrin sources, Biochem. Cell Biol., 99, 35, 10.1139/bcb-2020-0182

Horie, 2017, Bovine lactoferrin reduces extra-territorial facial allodynia/hyperalgesia following a trigeminal nerve injury in the rat, Brain Res., 1669, 89, 10.1016/j.brainres.2017.04.015

Lee, 2013, A current review of molecular mechanisms regarding osteoarthritis and pain, Gene, 25, 440, 10.1016/j.gene.2013.05.069

Hao, 2019, Lactoferrin: Major Physiological Functions and Applications, Curr. Protein Pept. Sci., 20, 139, 10.2174/1389203719666180514150921

Karav, S., German, J.B., Rouquié, C., Le Parc, A., and Barile, D. (2017). Studying lactoferrin N-glycosylation. Int. J. Mol. Sci., 18.

Kell, D.B., Heyden, E.L., and Pretorius, E. (2020). The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria. Front. Immunol., 11.

Sinha, M., Kaushik, S., Kaur, P., Sharma, S., and Singh, T.P. (2013). Antimicrobial lactoferrin peptides: The hidden players in the protective function of a multifunctional protein. Int. J. Pept., 2013.

Mayeur, 2016, Lactoferrin, a Pleiotropic Protein in Health and Disease, Antioxid. Redox Signal., 24, 813, 10.1089/ars.2015.6458

Piccinini, 2010, DAMPening inflammation by modulating TLR signalling, Mediat. Inflamm., 2010, 672395, 10.1155/2010/672395

Luna, 2012, Lactoferrin-lipopolysaccharide (LPS) binding as key to antibacterial and antiendotoxic effects, Int. Immunopharmacol., 12, 1, 10.1016/j.intimp.2011.11.002

Latorre, 2010, Reciprocal interactions between lactoferrin and bacterial endotoxins and their role in the regulation of the immune response, Toxins, 2, 54, 10.3390/toxins2010054

Takayama, 2017, Role of CXC chemokine receptor type 4 as a lactoferrin receptor 2, Biochem. Cell Biol., 95, 57, 10.1139/bcb-2016-0039

Fillebeen, 1999, Tumor necrosis factor-α increases lactoferrin transcytosis through the blood-brain barrier, J. Neurochem., 73, 2491, 10.1046/j.1471-4159.1999.0732491.x

Qiu, 2004, Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinase in primary neurons, J. Biol. Chem., 279, 34948, 10.1074/jbc.M401055200

Guzmán-Mejía, F., Godínez-Victoria, M., Vega-Bautista, A., Pacheco-Yépez, J., and Drago-Serrano, M.E. (2021). Intestinal homeostasis under stress siege. Int. J. Mol. Sci., 22.

Bertuccini, 2014, Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn’s disease, Dig. Liver Dis., 4646, 496, 10.1016/j.dld.2014.02.009

Kawakami, 1990, Iron uptake from transferrin and lactoferrin by rat intestinal brush-border membrane vesicles, Am. J. Physiol., 258, G535

Safaeian, 2014, Antioxidant Effects of Bovine Lactoferrin on Dexamethasone-Induced Hypertension in Rat, ISRN Pharmacol., 22, 1, 10.1155/2014/943523

Talukder, 2007, Bovine lactoferrin protects lipopolysaccharide-induced diarrhea modulating nitric oxide and prostaglandin E2 in mice, Can. J. Physiol. Pharmacol., 85, 200, 10.1139/Y07-004

Parlar, 2010, Effect of prolonged administration of bovine lactoferrin in neuropathic pain: Involvement of opioid receptors, nitric oxide and TNF-α, Life Sci., 86, 251, 10.1016/j.lfs.2009.12.007

El-Zayat, S.R., Sibaii, H., and Mannaa, F.A. (2019). Toll-like receptors activation, signaling, and targeting: An overview. Bull. Natl. Res. Cent., 43.

Rasheed, 2016, Lactoferrin from Camelus dromedarius inhibits nuclear transcription Factor-kappa B activation, cyclooxygenase-2 expression and prostaglandin E2 production in stimulated human chondrocytes, Pharmacogn. Res., 8, 135, 10.4103/0974-8490.175612

Salvi, V., Vaira, X., Gianello, V., Vermi, W., Bugatti, M., Sozzani, S., and Bosisio, D. (2016). TLR Signalling Pathways Diverge in Their Ability to Induce PGE2. Mediat. Inflamm., 2016.

Hu, 2020, Lactoferrin attenuates lipopolysaccharide-stimulated inflammatory responses and barrier impairment through the modulation of NF-κB/MAPK/Nrf2 pathways in IPEC-J2 cells, Food Funct., 11, 8516, 10.1039/D0FO01570A

Kong, 2020, Effects of Bovine Lactoferrin on Rat Intestinal Epithelial Cells, J. Pediatric Gastroenterol. Nutr., 70, 645, 10.1097/MPG.0000000000002636

Wisgrill, 2018, Human lactoferrin attenuates the proinflammatory response of neonatal monocyte-derived macrophages, Clin. Exp. Immunol., 192, 315, 10.1111/cei.13108

Kruzel, 2002, Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice, Clin. Exp. Immunol., 130, 25, 10.1046/j.1365-2249.2002.01956.x

Zemankova, N., Chlebova, K., Matiasovic, J., Prodelalova, J., Gebauer, J., and Faldyna, M. (2016). Bovine lactoferrin free of lipopolysaccharide can induce a proinflammatory response of macrophages. BMC Vet. Res., 12.

Baveye, 2000, Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex, Infect. Immun., 68, 6519, 10.1128/IAI.68.12.6519-6525.2000

Almeida, 2004, Afferent pain pathways: A neuroanatomical review, Brain Res., 1000, 40, 10.1016/j.brainres.2003.10.073

Sneddon, 2018, Comparative physiology of nociception and pain, Physiology, 33, 63, 10.1152/physiol.00022.2017

Hayashida, 2003, Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord, Am. J. Physiol. Regul. Integr. Comp. Physiol., 285, 306, 10.1152/ajpregu.00760.2002

Hayashida, 2004, Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis, J. Vet. Med. Sci., 66, 149, 10.1292/jvms.66.149

Harada, 1999, Characteristic transfer of colostral components into cerebrospinal fluid via serum in neonatal pigs, Biol. Neonate, 76, 33, 10.1159/000014129

Hayashida, 2004, Lactoferrin enhances peripheral opioid-mediated antinociception via nitric oxide in rats, Eur. J. Pharmacol., 484, 175, 10.1016/j.ejphar.2003.11.007

Faucheux, 1995, Expression of lactoferrin receptors in increased in the mesencephalon of patients with Parkinson disease, Proc. Natl. Acad. Sci. USA, 92, 9603, 10.1073/pnas.92.21.9603

Leveugle, 1996, Cellular distribution of the iron-binding protein lactotrasferrin in the mesencephalon of Parkinson´s disease cases, Acta Neurophathol., 91, 566, 10.1007/s004010050468

Huang, 2007, Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain, J. Biomed. Sci., 14, 121, 10.1007/s11373-006-9121-7

Suzuki, 2005, Mammalian lactoferrin receptors: Structure and function, Cell. Mol. Life Sci., 62, 2560, 10.1007/s00018-005-5371-1

Bennett, 2003, Models of Neuropathic Pain in the Rat, Curr. Protoc. Neurosci., 22, 9, 10.1002/0471142301.ns0914s22

Takahashi, 2011, IL-1beta in the trigeminal subnucleus caudalis contributes to extra-territorial allodynia/hyperalgesia following a trigeminal nerve injury, Eur. J. Pain, 15, 467.e1

Sasaki, 2010, Anti-nociceptive effect of bovine milk-derived lactoferrin in a rat lumbar disc herniation model, Spine, 35, 1663, 10.1097/BRS.0b013e3181c9a8e7

Sakurai, 2009, Oxaliplatin-induced neuropathy in the rat: Involvement of oxalate in cold hyperalgesia but not mechanical allodynia, Pain, 147, 165, 10.1016/j.pain.2009.09.003

Cersosimo, 2005, Oxaliplatin-associated neuropathy: A review, Ann. Pharmacother., 39, 128, 10.1345/aph.1E319

Wang, 2008, Involvement of the nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway in the antihyperalgesic effects of bovine lactoferrin in a model of neuropathic pain, Brain Res., 1209, 1, 10.1016/j.brainres.2008.03.004

Fujimura, 2020, The pain-relieving effects of lactoferrin on oxaliplatin-induced neuropathic pain, J. Vet. Med. Sci., 82, 1648, 10.1292/jvms.20-0034

Ma, 1998, Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries, Brain Res., 797, 243, 10.1016/S0006-8993(98)00380-1

Chan, 2000, Activation of transcription factors of nuclear factor kappa B, activator protein-1 and octamer factors in hyperalgesia, Eur. J. Pharmacol., 402, 61, 10.1016/S0014-2999(00)00431-3

Sakaue, 2001, NF-κB decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model, Neuroreport, 12, 2079, 10.1097/00001756-200107200-00008

Lee, 2004, Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity, Eur. J. Neurosci., 19, 3375, 10.1111/j.0953-816X.2004.03441.x

Haversen, 2002, Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB, Cell. Immunol., 220, 83, 10.1016/S0008-8749(03)00006-6

Inubushi, 2012, Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesis, J. Biol. Chem., 287, 23527, 10.1074/jbc.M111.324673

Zong, 2015, LFP-20, a porcine lactoferrin peptide, ameliorates LPS-induced inflammation via the MyD88/NF-κB and MyD88/MAPK signaling pathways, Dev. Comp. Immunol., 52, 123, 10.1016/j.dci.2015.05.006

Cury, 2011, Pain and analgesia: The dual effect of nitric oxide in the nociceptive system, Nitric Oxide, 25, 243, 10.1016/j.niox.2011.06.004

Meller, 1993, Nitric oxide (NO) and nociceptive processing in the spinal cord, Pain, 52, 127, 10.1016/0304-3959(93)90124-8

Kusuda, R., Carreira, E.U., Ulloa, L., Cunha, F.Q., Kanashiro, A., and Cunha, T.M. (2020). Choline attenuates inflammatory hyperalgesia activating nitric oxide/cGMP/ATP-sensitive potassium channels pathway. Brain Res., 15.

Izquierdo, 2018, Antiallodynic effect induced by [6]-gingerol in neuropathic rats is mediated by activation of the serotoninergic system and the nitric oxide–cyclic guanosine monophosphate–adenosine triphosphate-sensitive K+ channel pathway, Phyther. Res., 32, 2520, 10.1002/ptr.6191

2006, Pharmacological evidence for the participation of NO-cyclic GMP-PKG-K+ channel pathway in the antiallodynic action of resveratrol, Pharmacol. Biochem. Behav., 84, 535, 10.1016/j.pbb.2006.06.019

Duarte, 1992, The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway, Eur. J. Pharmacol., 221, 171, 10.1016/0014-2999(92)90789-7

Levy, 2004, Modulation of dural nociceptor mechanosensitivity by the nitric oxide-cyclic GMP signaling cascade, J. Neurophysiol., 92, 766, 10.1152/jn.00058.2004

Mercadante, 2019, Opioid-Induced Tolerance and Hyperalgesia, CNS Drugs, 33, 943, 10.1007/s40263-019-00660-0

Hong, 1995, Peripheral opioid modulation of pain and inflammation in the formalin test, Eur. J. Pharmacol., 277, 21, 10.1016/0014-2999(95)00045-M

Mousa, 2001, β-endorphin-containing memory-cells and μ-opioid receptors undergo transport to peripheral inflamed tissue, J. Neuroimmunol., 115, 71, 10.1016/S0165-5728(01)00271-5

Wenk, 1999, Immunohistochemical localization of delta opioid receptors in peripheral tissues, J. Comp. Neurol., 408, 567, 10.1002/(SICI)1096-9861(19990614)408:4<567::AID-CNE10>3.0.CO;2-Q

Ferreira, 1991, The molecular mechanism of action of peripheral morphine analgesia: Stimulation of the cGMP system via nitric oxide release, Eur. J. Pharmacol., 201, 121, 10.1016/0014-2999(91)90333-L

Cunha, 2012, Stimulation of Peripheral Kappa Opioid Receptors Inhibits Inflammatory Hyperalgesia via Activation of the PI3Kγ/AKT/nNOS/NO Signaling Pathway, Mol. Pain, 8, 1744, 10.1186/1744-8069-8-10

Cunha, 2010, Morphine peripheral analgesia depends on activation of the PI3K /AKT/nNOS/NO/KATP signaling pathway, Proc. Natl. Acad. Sci. USA, 107, 4442, 10.1073/pnas.0914733107

Tsuchiya, 2006, Milk-derived lactoferrin may block tolerance to morphine analgesia, Brain Res., 1068, 102, 10.1016/j.brainres.2005.11.002

Li, H., Wang, Y., Yang, H., Liu, L., Wang, J., and Zheng, N. (2019). Lactoferrin Induces the Synthesis of Vitamin B6 and Protects HUVEC Functions by Activating PDXP and the PI3K/AKT/ERK1/2 Pathway. Int. J. Mol. Sci., 20.

Lee, 2009, Iron-saturated lactoferrin stimulates cell cycle progression through PI3K/Akt pathway, Mol. Cells, 28, 37, 10.1007/s10059-009-0102-3